OneSource Specialty Pharma Limited (BOM:544292)
1,614.10
+10.70 (0.67%)
At close: Nov 20, 2026
BOM:544292 Revenue
OneSource Specialty Pharma had revenue of 5.16B INR in the quarter ending September 30, 2026, with 37.39% growth. This brings the company's total for the last twelve months to 16.86B, up 10.77% year-over-year. In the fiscal year ending March 31, 2026, OneSource Specialty Pharma had annual revenue of 14.23B, down -1.49%.
Revenue (ttm)
16.86B
Revenue Growth
+10.77%
P/S Ratio
10.95
Revenue / Employee
10.07M
Employees
1,674
Market Cap
184.54B
Revenue by Geography
- United States of America 4.93B 34.7%
- India 3.96B 27.9%
- Rest of The World 3.08B 21.7%
- Spain 1.54B 10.8%
- Ireland 699.56M 4.9%
Fiscal year ended Mar 31, 2026 See the full BOM:544292 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 14.23B | -215.98M | -1.49% |
| Mar 31, 2025 | 14.45B | 12.73B | 740.50% |
| Mar 31, 2024 | 1.72B | 1.33B | 344.07% |
| Mar 31, 2023 | 387.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
OneSource Specialty Pharma News
- 26 days ago - OneSource Specialty Pharma Transcript: Q2 26/27 - Transcripts
- 26 days ago - OneSource Specialty Pharma Quarterly report: Q2 2027 - Filings
- 26 days ago - OneSource Specialty Pharma Slides: Q2 2027 - Filings
- 4 months ago - OneSource Specialty Pharma Transcript: Q1 26/27 - Transcripts
- 4 months ago - OneSource Specialty Pharma Quarterly report: Q1 2027 - Filings
- 4 months ago - OneSource Specialty Pharma Slides: Q1 2027 - Filings
- 6 months ago - OneSource Specialty Pharma Transcript: Q4 25/26 - Transcripts
- 6 months ago - OneSource Specialty Pharma Slides: Q4 2026 - Filings